Cronics, Inc. Competitors

Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the Life Sciences industry. We are already trusted to support over 700 active clinical trials and we support the leading commercial therapies worldwide, delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management. As the Life Sciences constantly evolve and advance, so do we.

We make people’s dream of having a child come true by providing a wide selection of high-quality, extensively screened sperm and egg donors of all ethnicities and phenotypes. WORK WITH US Give your patients the world’s largest selection of sperm donors, and high-quality egg donors. Get a trusted partner, with over 30 years of experience and the highest number of registered donor-conceived children in the world. Experience quality throughout our collaboration. Cryos is certified under the international standard for quality management ISO 9001:2015. Reach out for questions and guidance Cryos International – The World's Largest Sperm Bank Phone: +45 8676 0699 E-mail: info@cryosinternational.com Cryos International USA – International Sperm & Egg Bank Phone: +1(407) 203-1175 E-mail: usa@cryosinternational.com Cryos IVF Cyprus Phone: 00357 22007656 Email: cy@cryosinternational.com WORK AT CRYOS You know that feeling when you look at a picture of a cute baby, and you cannot help but smile? That feeling gets even better, when you know, that your work has contributed to bringing that child into the world. That is what we do at Cryos. Our jobs go past our titles. Every task we complete, even those usually thought mundane, all contributes to making couples’ and singles’ dream of having a baby come true.

NantKwest (NASDAQ: NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify and destroy cells under stress, such as cancer or virally-infected cells. NantKwest is uniquely positioned to implement precision cancer medicine, with the potential to change the current paradigm of cancer care. Natural Killer cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. Our “off-the-shelf” activated Natural Killer (NK) platform have the capacity to destroy cancer and virally infected cells from the body. The safety of our NK cells as well as their activity against a broad range of cancers have been tested in multiple phase 1 clinical trials in the United States, Canada and Europe. In addition to our NK cells capability to be administered in the outpatient setting as an “off-the-shelf” living drug, it serves as a universal cell-based therapy without need for individualized patient matching. Moreover, our NK cell based platform has been bioengineered to incorporate chimeric antigen receptors (CARs) and antibody receptors to further optimize targeting and potency in the therapeutic disease. Our targeted therapeutic areas include: (1) cancer, focusing on bulky hematological cancers and solid tumors as well as cancer stem cells, (2) infectious diseases, including viral, fungal and bacterial infections, and (3) inflammatory diseases, ranging from rare inherited diseases to more prevalent autoimmune disorders.